Bloomberg News

Roche Raises Illumina Takeover Bid to $51 a Share

March 29, 2012

Tablets of Roche Holding AG's Tarceva cancer drug are arranged for a photograph. Photographer: JB Reed/Bloomberg

Tablets of Roche Holding AG's Tarceva cancer drug are arranged for a photograph. Photographer: JB Reed/Bloomberg

Roche Holding AG (ROG) raised its bid for Illumina Inc. (ILMN:US) to $51 a share. The company commented in a statement today.

To contact the editor responsible for this story: Thomas Mulier at tmulier@bloomberg.net


Burger King's Young Buns
LIMITED-TIME OFFER SUBSCRIBE NOW

(enter your email)
(enter up to 5 email addresses, separated by commas)

Max 250 characters

Companies Mentioned

  • ILMN
    (Illumina Inc)
    • $166.08 USD
    • -4.95
    • -2.98%
Market data is delayed at least 15 minutes.
 
blog comments powered by Disqus